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Abstract
Objective To translate and assess the psychometric properties of
the 9-item Shared Decision-Making Questionnaire (SDM-Q-9) for
measuring patients’ perceptions of how clinicians’ performance ﬁts
the SDM process.
Design Cross-sectional study.
Setting and Participants Data were collected in primary care
health centres. Patients suﬀering from chronic diseases and facing
a medical decision were included in the study.
Measurements The original German SDM-Q-9 was translated to
Spanish using the process of cross-cultural adaptation of self-
reported measures as the methodological model for Spanish trans-
lation. Reliability (internal consistency) and construct validity
[exploratory (EFA) and conﬁrmatory factor analysis (CFA)] were
assessed.
Results The ﬁnal Spanish version of the SDM-Q-9 was tested in a
primary care sample of 540 patients. The SDM-Q-9 presented ade-
quate reliability and acceptable validity. Internal consistency
yielded a Cronbach’s alpha of 0.885 for the whole scale. EFA
showed a two-factorial solution, and for the CFA, the best solu-
tion was obtained with a one-dimensional factor with the item 1
excluded, which produced the best indexes of ﬁt.
Discussion and Conclusions The Spanish version of the SDM-Q-9
showed adequate reliability and acceptable validity parameters
among primary care patients. The SDM-Q-9 is suitable for use in
Spain and other Spanish-speaking countries with similarly orga-
nized health-care systems. The use of the SDM-Q-9 may contri-
bute to the evaluation of SDM process from the patient’s
perspective.
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Introduction
Over the last few decades, there has been an
increasing emphasis on patient participation in
clinical decision making, with the new role of
the patient as an active agent, manager and
producer of his or her own health, and the par-
adigm of patient-centred care. The involvement
of patients is a new way of understanding the
relationship between patients, health profes-
sionals and health-care systems, and one way
to address this is by involving patients in a
shared decision-making (SDM) process1.
Shared decision making is an interactive pro-
cess of clinical decision making that ensures
that both patient and physician are equally and
actively involved and share information to
reach an agreement, for which they are jointly
responsible2. The last years have seen a clear
move towards SDM and increased patient
involvement in many countries. At present
time, the Spanish National Health System rec-
ognizes the importance of considering patients’
values and preferences in clinical decisions with
patient participation in SDM gaining impor-
tance as a suitable approach to patient–health
professional communication and decision mak-
ing in Spain3. However, not all patients are
prepared or want to participate to the same
degree in the process of making decisions
about the treatment of their disease. Achieving
SDM in clinical practice depends on the will-
ingness of both patients and health-care profes-
sionals to engage in it, the skills to do it,
decision aids or reliable information to facili-
tate the process and wider support from the
health-care organization4.
We have observed a positive attitude
towards SDM both in professionals and among
patients5–7, but further studies were needed to
address the extent to which this apparently
accepted model is reﬂected in the daily practice
of health professionals.
Appraisal of eﬃcacy of SDM closely depends
on the quality of measurement methods.
According to recent reviews of the literature8–11,
diﬀerent instruments are available to assess dif-
ferent aspects of SDM, but only few have been
evaluated formally for reliability, validity and
responsiveness. Even though a great number of
translations have been made into several lan-
guages, no Spanish short scale for assessing the
patient’s perception of clinician facilitation of
the SDM process is available.
In Spain, the importance of patient participa-
tion in health-care decisions has achieved grow-
ing recognition in the National Health System.
In particular, some health technology assessment
units in Spain have been reviewing the methods
to develop patient decision aids (PtDAs) and
producing some PtDAs themselves7. As these
intervention strategies need adequate measures
to evaluate their eﬀectiveness and for the pur-
pose of fully capturing process and eﬀects of
SDM, both the views of physicians and patients
robust measures are needed to enable compari-
sons and conclusions8–11.
The 9-item Shared Decision-Making Ques-
tionnaire (SDM-Q-9)12 is a brief and easy-
to-administer patient-report instrument for
measuring SDM process in clinical encounters
and a theory-driven instrument for assessing
the process of SDM from the patient’s perspec-
tive11, which considers the Elwyn’s model of
competences for involving patients13, theories
from general psychology14 and decision analy-
sis, which can also be found in the Ottawa
Decision Support Framework15. The psycho-
metric properties of the scale have been exam-
ined both in primary and in secondary
outpatient care samples. The SDM-Q-9 has
shown good acceptability, reliability and valid-
ity as indicated by good response rates (≥80%),
high internal consistency (Cronbach’s
alpha > 0.9) and high item discriminations, as
well as high face and factorial validity. Factor
analyses have revealed that the scale has a one-
dimensional structure. The SDM-Q-9 can be
used in studies assessing the eﬀectiveness of
interventions aimed at the implementation of
SDM and as a quality indicator in health
services assessments12,16–18.
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The aim of the present study was to assess
the psychometric properties of a Spanish
version of the SDM-Q-9 and to test the
reliability and factorial validity of this brief
instrument to measure the process of SDM in
clinical encounters from the patient’s
perspective.
Methods
Instrument
The nine-item Shared Decision-Making Ques-
tionnaire is a brief tool that assesses the
patient’s view of the decision-making process
in a consultation (Table 1) 12. The question-
naire consists of nine items each describing one
step of the SDM process19. The questionnaire
was developed to show the extent to which
patients feel they were involved in the process
through nine items scoring from 0 to 5 on a 6-
point Likert scale.
Questionnaire translation
We used the guidelines described for Beaton
et al.20 for the process of cross-cultural adapta-
tion of self-reported measures as the methodo-
logical model for Spanish translation. In this
model, ﬁve distinct steps were followed by the
researchers. In the ﬁrst step, translation, two
independent bilingual translators, competent in
both German and Spanish, translated the origi-
nal questionnaire from German into Spanish.
In the second step, translators reached consen-
sus on the translation of words, phrases and
items based on the synthesis of the transla-
tions, working from the original questionnaire
as well as the ﬁrst translator’s and the second
translator’s versions.
The third step was cultural appropriateness
and content validity testing, which was per-
formed by ﬁve independent primary care physi-
cians, psychiatrists and psychologists. They
rated degree that each item of the instrument
covers the content that it is supposed to mea-
sure as an index for representativeness and
content validity. They also rated understand-
ability and translation equivalence (semantic
and content equivalence) between German and
Spanish version.
In the fourth step, the revised Spanish ver-
sion was back-translated by another two bilin-
gual translators who were blind to the original
German version. This step assured that the
meaning of Spanish version was reﬂected in the
back-translation version.
The ﬁnal step was equivalence testing. In this
step, the original authors (IS, MH) were asked
to review and compare the original version in
German and the back-translated version in
German of the SDM-Q-9. Following this step,
the back-translation was compared with origi-
nal questionnaire by the study directors from
Spain (DC, LP, AR), and after some minor
revisions, the Spanish version was ready to use
(Table 2). After this translation process, the
ﬁnal version was pre-tested with the ﬁrst twelve
adult patients attended at the two primary care
health centres who were invited to participate
in this study. Their responses were analysed to
identify necessary modiﬁcations; however, it
was not necessary to make any modiﬁcation
after this pre-test.
Study sample and procedure
Along August 2012, 795 consecutive adult
patients (older than 18 years of age) attended
at two primary care health centres (one urban
and one suburban) in Tenerife (Canary Islands,
Spain) were invited to participate in the study.
Each participant received a written full expla-
nation of the study, after which they signed an
informed consent document approved by the
local ethics committee. Each patient completed
immediately after her/his clinical consultation
with their general practitioner, and not in the
presence of the treating health professional, an
anonymous questionnaire that included the
patient’s socio-demographic variables (sex, age
and educational level), clinical variables
(appointment type, self-reported diagnosis and
treatment decision), health professional vari-
ables (doctor, sex and age) and the ‘9-Item
Shared Decision-Making Questionnaire’
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Table 1 Items and contents of the SDM-Q-9, response distribution, means, standard deviations and corrected item-total
correlations (n = 540)
Items and contents
of the SDM-Q-912,14
Completely
disagree
(%)
Strongly
disagree
(%)
Somewhat
disagree
(%)
Somewhat
agree (%)
Strongly
agree (%)
Completely
agree (%) Mean (SD)
Corrected
item-total
correlation
1. My doctor made
clear that a
decision needs to
be made
(recognizing that
a decision needs
to be made)
3 5.9 9.4 19.1 28.7 33.9 3.66 (1.34) 0.272**
2. My doctor
wanted to know
exactly how I
want to be
involved in
making the
decision (asking
for preferred
involvement in
decision making)
9.8 8.1 13.5 22.6 25.7 20.2 3.07 (1.55) 0.594**
3. My doctor told
me that there are
different options
for treating my
medical condition
(informing that
different options
are available)
5.4 5.9 9.4 18.9 27.6 32.8 3.56 (1.45) 0.682**
4. My doctor
precisely
explained the
advantages and
disadvantages of
the treatment
options
(explaining on the
options’
advantages and
disadvantages)
5.4 5 9.4 18.5 28.1 33.5 3.60 (1.43) 0.634**
5. My doctor helped
me understand
the information
(helping to
understand the
information)
1.9 2.2 4.6 10.4 22.8 58.1 4.24 (1.14) 0.516**
6. My doctor asked
me which
treatment option I
prefer (asking for
preferred option)
10.7 9.3 14.8 16.9 23.7 24.6 3.07 (1.65) 0.754**
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(SDM-Q-9). To rate the SDM-Q-9, partici-
pants were instructed to think about their last
consultation and to use this consultation as a
reference for the rating. Questionnaires were
self-administered in all cases. Patients did not
receive any ﬁnancial compensation for partici-
pating.
We considered two appointment types as fol-
lows: Follow-up scheduled appointments that
correspond to patients who have any medical
condition that should be scheduled for planned
follow-up visits at periodic interval to assess
their condition control and modify treatment if
needed and included prescription reﬁlls; and
non-scheduled consultations that involve
patients seeking non-scheduled medical care in
situations they perceive as a medical emer-
gency, but many times may not be a true emer-
gency.
Treatment decisions options were categorized
as follows: prescription of a new treatment,
maintenance of the previous treatment and
modification of the previous treatment by
increasing or decreasing dosages of the drug
treatment.
The study was carried out in accordance
with the Code of Ethics of the Declaration of
Helsinki, and all procedures and consent forms
were reviewed and approved by the Ethics
Committee of the University Hospital Nuestra
Se~nora de la Candelaria (Spain).
Data analysis
Demographic information for non-participants
was collected. Age means and sex distribu-
tions were compared between participants and
non-participants using t-test and v2 test,
respectively. Item analysis included the obser-
vation of the ceiling eﬀect obtained (percent-
age of patients scoring on the category
‘completely agree’ for each item), the cor-
rected item-total correlations, and item means
and standard deviations. Internal consistency
of the scale was assessed with Cronbach’s
alpha. These analyses were performed for the
whole sample and also by demographic (gen-
der, age and education), appointment type
(follow-up scheduled appointments and non-
scheduled consultation) and treatment (new
Table 1. Continued
Items and contents
of the SDM-Q-912,14
Completely
disagree
(%)
Strongly
disagree
(%)
Somewhat
disagree
(%)
Somewhat
agree (%)
Strongly
agree (%)
Completely
agree (%) Mean (SD)
Corrected
item-total
correlation
7. My doctor and I
thoroughly
weighed the
different
treatment options
(weighing the
options)
8.5 9.1 14.6 21.5 24.8 21.5 3.09 (1.54) 0.820**
8. My doctor and I
selected a
treatment option
together
(selecting an
option)
19.6 9.8 12 17.2 20.7 20.6 2.71 (1.80) 0.744**
9. My doctor and I
reached an
agreement on
how to proceed
(agreeing on how
to proceed)
11.3 6.1 9.4 14.3 25.6 33.3 3.37 (1.68) 0.685**
**P < 0.001.
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prescription, maintenance of previous treat-
ment and modiﬁcation of previous treatment)
subgroups.
Factor analysis is a statistical method used to
describe variability among observed and corre-
lated variables in terms of a potentially lower
number of unobserved variables called factors.
The theoretical framework from which the
SDM-Q-9 has been developed conceptualizes
the perception of SDM as a latent construct (a
psychological experience of involvement) that
can be measured by some indicators (i.e. the
items of the scale). Therefore, factor analysis
techniques were used to assess the scale’s
dimensionality. First, the sample was randomly
split into two groups. A principal components
analysis (PCA) with oblimin rotation was per-
formed in the ﬁrst split-half sample, extracting
components with eigenvalues >1. Adjustment of
the structure obtained was then tested with a
conﬁrmatory factor analysis (CFA). Maximum
likelihood with robust correction was used to
avoid distributional problems in the data set. A
range of global goodness of ﬁt indices was used
to assess the degree to which observed data
were accounted for by the proposed models:
comparative ﬁt indexes (CFI), goodness of ﬁt
index (GFI), root mean square error of approx-
imation (RMSEA) and standardized root mean
square residual (SRMR). According to Hu and
Bentler21, the following criteria were used to
indicate the ﬁt of the CFA models to the data:
Table 2 The Spanish version of the 9-item Shared Decision-Making Questionnaire (SDM-Q-9)
¿Por que motivo acudio a su medico (p. ej. con que sı´ntomas, diagnostico, problema de salud)?
¿Que decision se tomo (p. ej. iniciar un tratamiento nuevo, seguir con el tratamiento previo, cambiar a otro tratamiento,
finalizar el tratamiento)
Las siguientes afirmaciones estan relacionadas con la experiencia que ha tenido en la consulta con su medico. Por favor,
marque con una cruz su nivel de acuerdo o desacuerdo con estas afirmaciones
Totalmente
en desacuerdo
Muy en
desacuerdo
Algo en
desacuerdo
Algo de
acuerdo
Muy de
acuerdo
Totalmente
de acuerdo
1. Mi medico me dijo
expresamente que debı´a
tomarse una decision
2. Mi medico querı´a saber
exactamente como me
gustarı´a participar en
la toma de decisiones
3. Mi medico me informo
de que existen distintas
opciones de tratamiento
para mi problema de salud
4. Mi medico me explico
con exactitud las ventajas y
desventajas de las distintas
opciones de tratamiento
5. Mi medico me ayudo a
entender toda la informacion
6. Mi medico me pregunto
que opcion de tratamiento prefiero
7. Mi medico y yo valoramos
con detenimiento las
distintas opciones de tratamiento
8. Mi medico y yo elegimos
juntos una opcion de tratamiento
9. Mi medico y yo llegamos a
un acuerdo sobre el modo
de proceder
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CFI and GFI > 0.90, and RMSEA and
SRMR < 0.08. These ﬁt statistics and the chi-
square were selected because of previous
research that demonstrated their performance
and stability21,22. CFA was performed with
EQS software for Windows version 6.123,
whereas for the remaining analyses, SPSS ver-
sion 12 was used.
Finally, t-test and Pearson correlations were
used to assess the relationship between total
scores in the scale and patients and physicians’
gender and age, respectively. A one-way analy-
sis of variance (ANOVA) was performed to assess
diﬀerences between the types of treatment deci-
sions on the SDM-Q-9.
Results
Sample characteristics
Seven hundred and ninety-ﬁve patients were
invited to participate and 540 (67.9%)
accepted. Non-participants were signiﬁcantly
older than participants (47.6  15.8 vs.
44.7  16.4, respectively; t = 2.32, P = 0.02)
and included more men (40% vs. 29.8%;
v2 = 7.66, P = 0.006). Among participants, age
ranged between 18 and 87, 11.9% had no for-
mal education, 40.9% had completed primary
education, 33.7% had completed secondary
education, and 13.5% had a university degree.
Descriptive analyses of the SDM-Q-9 items and
reliability analysis
Table 1 shows responses distribution, means,
standard deviations and the corrected item-
total correlation for each item. Item 5 shows a
ceiling eﬀect (58.1%), with a percentage range
of 20.2–33.9 for the other eight items. Items
means ranged from 2.71 (item 8) to 4.24 (item
5), although the majority of them obtained
scores between 3 and 3.6 (between ‘somewhat
agree’ and ‘strongly agree’). Item 1 obtained a
low corrected item-total correlation (r = 0.27),
and the remaining showed values that ranged
between 0.52 and 0.82. Cronbach’s alpha for
the whole scale was 0.885.
Table 3 shows these psychometric properties
by demographic and treatment subgroups.
Results in subgroups are comparable to results
in the total sample, with item 5 showing a ceil-
ing eﬀect and item 1 obtaining the lowest item-
total correlations. However, a slightly diﬀerent
pattern can be observed for younger partici-
pants and those with a higher educational
level, who show lower mean item scores.
Factor structure
To assess the factor structure of the scale, sam-
ple was randomly split into two groups. PCA
was performed on the ﬁrst split-half sample.
The Kaiser–Meyer–Olkin value was 0.821, and
the Barlett sphericity test was statistically sig-
niﬁcant (v2 = 1289.7, df = 36, <0.001) indicat-
ing that a factor analysis of the data was
appropriate. PCA yielded two components
with eigenvalues >1. Table 4 shows this two-
factorial solution. Before oblimin rotation, the
two components explain 51.1% and 12.5% of
the variance, respectively. Items 3–9 loaded
above 0.5 on the ﬁrst component, whereas
items 1 and 2 showed their highest loadings on
the second component. Item 1 obtained a fac-
tor loading of 0.92, so this component was
almost exclusively represented by this item.
A CFA was performed in the second split-
half sample (Table 5). Considering that the
original scale showed a unidimensional struc-
ture12 and the results obtained in the PCA,
three diﬀerent models were tested: the original
one-factor model, representing the nine items
(Model 1); the structure obtained with PCA in
the current sample, composed by two factors
(Model 2); and a monofactorial structure but
excluding item 1 (Model 3). The best solution
was obtained with the one-factor structure with
the item 1 excluded (Model 3), and it produced
the best indexes of ﬁt (CFI and GFI).
Association with patient and practitioner
characteristics
Scores on the total scale were not related to
patient gender, but they were signiﬁcantly asso-
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ciated with the gender of the physician, with
males obtaining better scores than women
(t = 2.44; P = 0.015). Both patients and physi-
cians’ age was statistically signiﬁcantly but
weakly related to total scale scores (r = 0.13,
P = 0.02 and r = 0.19, P < 0.001, respectively).
Patients with follow-up scheduled appoint-
ments scored statistically signiﬁcantly higher
than those with non-scheduled consultations
(t = 2.289, P = 0.022). Finally, an ANOVA with
the type of treatment decision as independent
variable was statistically signiﬁcant (F = 3.791,
P = 0.023): patients whose treatments were
Table 5 Results of the confirmatory factor analysis (CFA)
Model v2 CFI GFI SRMR
RMSEA (Confidence
interval)
Model 1 134.80* 0.903 0.840 0.077 0.122 (0.101–0.142)
Model 2 127.26* 0.909 0.840 0.077 0.120 (0.100–0.141)
Model 3 105.03* 0.921 0.856 0.072 0.126 (0.102–0.149)
CFI, comparative fit index; GFI, goodness of fit index; SRMR, standardized root mean square residual; RMSEA, root mean square error of
approximation recommended values: CFI and GFI > 0.90; SRMR and RMSEA < 0.08.
*P < 0.001.
Table 3 Ceiling effect, means, standard deviations and corrected item-total correlations, by socio-demographic and treatment
subgroups (n = 540)
n
Ceiling effect
(% completely
agree) range
Corrected
item-total
correlation
range Mean range
Internal
consistency
(Cronbach’s alpha)
Gender
Female 379 20.1–57.5 0.314–0.841 2.74–4.24 0.89
Male 161 19.3–59.6 0.175–0.779 2.65–4.25 0.872
Age
18–40 225 16.0–52.0 0.353–0.795 2.45–4.07 0.89
41–60 213 22.5–60.6 0.180–0.805 3.08–4.35 0.876
>60 102 20.6–66.7 0.176–0.887 2.54–4.41 0.87
Education
No formal education 64 17.2–64.1 0.177–0.867 2.30–4.39 0.862
Primary studies 221 22.2–62.0 0.270–0.839 3.07–4.35 0.891
Secondary studies 182 15.9–56.0 0.303–0.785 2.62–4.20 0.873
University degree 73 13.7–46.6 0.311–0.801 2.25–3.90 0.902
Follow-up scheduled
appointment
269 20.1–58.4 0.308–0.835 2.88–4.26 0.886
Non-scheduled consultation 271 19.2–57.9 0.244–0.803 2.55–4.23 0.822
New prescription 319 17.6–55.2 0.281–0.798 2.64–4.18 0.882
Maintenance previous 187 17.6–61.5 0.250–0.847 2.78–4.32 0.888
Modification previous 34 26.5–67.6 0.140–0.855 3.06–4.41 0.869
Table 4 PCA solution (oblimin rotation). Factor loadings
higher than 0.50 are in bold
Item no Component 1 Component 2 h2
1. 0.11 0.92 0.794
2. 0.29 0.66 0.648
3. 0.81 0.04 0.631
4. 0.76 0.06 0.544
5. 0.57 0.27 0.334
6. 0.77 0.15 0.683
7. 0.88 0.04 0.791
8. 0.76 0.14 0.673
9. 0.83 0.14 0.628
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modiﬁed scored higher than those that received
a new prescription (P = 0.044), while those that
remained on their treatments did not diﬀer
signiﬁcantly from the other two groups.
Discussion
This study reports the psychometric character-
istics of the Spanish version of the SDM-Q-9
in a sample of primary care patients. The
translation and validation of the SDM-Q-9 in
Spain have followed international multiphase
translation guidelines to assure accurate con-
tent and semantic equivalence as well as con-
struct validity20. Although the SDM-Q-9 and
other instruments are available to evaluate the
various aspects of SDM8–11, the newly trans-
lated Spanish version of the SDM-Q-9 is the
ﬁrst psychometrically tested instrument to
assess the process of SDM from the patient’s
perspective in Spanish.
The Spanish version of the SDM-Q-9 has
demonstrated good reliability and factorial
validity. Internal consistency, as determined by
the Cronbach’s alpha coeﬃcient for the whole
scale, was considered to be adequate in this
study (Cronbach’s alpha = 0.89) and the cor-
rected item-total correlations ranging from 0.52
to 0.82 (except for item 1, which had the lower
value, r = 0.27). The results were similar to
those of Kriston et al.12 and Scholl et al. 16, in
which the Cronbach’s alpha values were 0.94
and 0.92, respectively, and the corrected item-
total correlations ranged from 0.69 to 0.8512
and from 0.52 to 0.8516.
In the PCA, we found a two-factorial solu-
tion. All nine items had an adequate factor
loading. In factor 1, items 3–9 had factor load-
ings >0.5, and items 1 and 2 had factor load-
ings >0.5 in factor 2 (mostly represented by
item 1). Nevertheless, given that the factorial
validation of the original version showed a
clear one-dimensional structure12, we decided
to test this hypothesis and we found in the
CFA that the structure of the hypothesized
one-factor model was consistent with the data
and that the model provided acceptable ﬁt with
the observed variables. The correlation between
items veriﬁed in this study was in the same
direction as previous studies, although correla-
tions are somewhat lower than those obtained
by Kriston et al.18 The main problem is with
item 1 (‘My doctor made clear that a decision
needs to be made’), which correlates little with
others. Similar results were reported in previ-
ous studies, where Kriston et al.18 also found
that item one is a bit separate from the others,
and Scholl et al.,17 on the physician version
(SDM-Q-Doc) also found that item 1 had the
lowest factor loadings.
Some limitations of the present study should
be considered. The present study included a
convenience sample of patients with diﬀerent
backgrounds which could have biased our
results. Also, the non-participants were signiﬁ-
cantly older than participants and included
more men. In this sense, this sample may not
be representative of the entire population
attending primary health-care settings. How-
ever, considering that the educational charac-
teristics of the patients in this study are
correspondent to those of the Spanish
population, we may have mitigated the afore-
mentioned limitation.
Another limitation to our results refers to
the wide range of medical topics that are con-
sidered within the decision-making consulta-
tions in primary care. The Spanish version of
the SDM-Q-9 presented adequate reliability
and acceptable validity parameters among pri-
mary care patients, which indicates that the
scale appears to yield accurate measurement,
but only the repeated use of the questionnaire
by testing the scale in clinically more heteroge-
neous samples (mental health problems, can-
cer. . .) and in situations where the complexity
of decision making is greater will determine the
validity of the inferential process, which will
indicate that the questionnaire repeatedly gen-
erates reliable and valid data.
An additional issue to consider when we use
a self-reported measure is that measures such
as this may not accurately reﬂect respondents’
experiences, expectations and behaviour. Social
desirability and inaccurate recall must be taken
into account when interpreting our results16.
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Conclusion
Our ﬁndings suggest that the Spanish transla-
tion of the SDM-Q-9 is suitable for use in
Spain and other countries with similarly orga-
nized health-care systems. Considering some
cultural similarities between Spain and develop-
ing countries, the Spanish version of the SDM-
Q-9 could also be useful in other countries
where Spanish is spoken.
The current results contribute to research on
SDM process in clinical practice and may have
important clinical implications. The Spanish ver-
sion of the SDM-Q-9 may be used to evaluate the
eﬀectiveness of SDM implementation strategies
and as a quality indicator in health-care pro-
grammes and health services research. The ques-
tionnaire may facilitate measurement of patients’
perceived level of involvement in decision making
about their own treatment and care, which, in
turn, could provide rapid feedback to health pro-
fessionals, enabling them to monitor their own
practice and address any associated training/prac-
tical issues. Furthermore, the use of the SDM-Q-9
may be a valuable reminder to health profession-
als to think about SDM in their consultations.
Use of the SDM-Q-9 allows further expan-
sion of this ﬁeld of study in Spanish context,
resulting in better insight into the nature, pre-
dictors, eﬀects and implications for implemen-
tation of SDM in clinical practice. Conﬁdence
in the cross-cultural validity of the SDM-Q-9
enables its use in diﬀerent countries, allowing
direct comparisons between patients’ views on
the SDM process internationally. Ultimately,
this could improve patient care.
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